Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Does Electrocardiogram Offer an Alternative to Radiological Imaging in the Confirmation of Tip Positioning for the Insertion of Peripherally Inserted Central Catheters; A Comparison of 120 Patients

Sasha D Brimacombe, Bsc (Hons) Cancer Care, Lisa McMonagle, BSc Adult Nursing, Ashutosh Wechalekar, Dr, Christopher J McNamara

Blood (2014) 124 (21): 1314.

https://doi.org/10.1182/blood.V124.21.1314.1314

Published: 2014

Journal Articles

Clinico-Pathologic Characteristics of Patients Experiencing Severe Pyrimethamine Poisoning

Mercedes Gasior, Hasan Ahmad, Stephen M. Hart, PhD, Christopher J McNamara, -

Blood (2012) 120 (21): 5162.

https://doi.org/10.1182/blood.V120.21.5162.5162

Published: 2012

Journal Articles

Young Adults Aged 18 to 30 Years with Hodgkin Lymphoma Can Tolerate a Modified Version of the Combined Modality German Paediatric HD95 Protocol with Minimal Neurotoxicity and Excellent Outcome. Results of the UK NCRN 18–30 Study (CRUK/08/012)

Kirit M Ardeshna, MD, Peter Hoskin, Paul Smith, PhD, Nicholas Chadwick, Nivette Braganca, Wai-Lup Wong, MD, Irfan Kayani, Bal Sanghera, Patricia Diez, Helen Lucraft, Andrew Jack, PhD, MB, Christopher J McNamara, George Mikhaeel, MD, Scott Marshall, MD, Ruth Pettengell, Robert E. Marcus, MBBS, FRCP, FRCPath, Anton Kruger, David C Linch, MD FMedSci

Blood (2012) 120 (21): 1621.

https://doi.org/10.1182/blood.V120.21.1621.1621

Published: 2012

Journal Articles

Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively

Sylvie Freeman, Robert Hills, MA, MSc, DPhil, Paul Virgo, Steve Couzens, Mark W Lowdell, BSc, MSc, PhD, FRCPath, Christopher J McNamara, Paul White, Alan Burnett

Blood (2010) 116 (21): 2714.

https://doi.org/10.1182/blood.V116.21.2714.2714

Published: 2010

Journal Articles

the Utility of CD200 Expression In the Differentiation of Mantle Cell Lymphoma and B-Cell Chronic Lymphocytic Leukaemia: A Single Centre Experience.

Neha Bhatnagar, MBChB, MRCPCH, Faith Wright, Dimpna McAleese, Christopher J McNamara

Blood (2010) 116 (21): 1673.

https://doi.org/10.1182/blood.V116.21.1673.1673

Published: 2010

Journal Articles

The JAK2 V617F Mutation but NOT Platelet Parameters Predict Thrombotic RISK IN Patients with Philadelphia-Negative MYELOPROLIFERATIVE Disorders (MPDs).

Deepti Wijayasinghe, MBBS, Stephen Hart, PhD, Saida Solkar, Christopher j McNamara

Blood (2009) 114 (22): 4984.

https://doi.org/10.1182/blood.V114.22.4984.4984

Published: 2009

Journal Articles

Rituximab Does Not Increase the Complication Rate, Particularly Perforation, When Added to Chemotherapy for Patients with Primary B-Cell Lymphomas of the Gastrointestinal Tract.

Shireen A. Kassam, MRCP, Anthony H. Goldstone, FRCP, A. V. Hoffbrand, FRCP, Miguel Perez-Machado, MBBS, Nicola Cooper, MRCP, Panos Kottaridis, MRCP, Archie Prentice, FRCP, Derralyn Hughes, MRCP, Christopher J. McNamara, FRACP, FRCPA

Blood (2005) 106 (11): 4742.

https://doi.org/10.1182/blood.V106.11.4742.4742

Published: 2005

NARROW

Does Electrocardiogram Offer an Alternative to Radiological Imaging in the Confirmation of Tip Positioning for the Insertion of Peripherally Inserted Central Catheters; A Comparison of 120 Patients

Clinico-Pathologic Characteristics of Patients Experiencing Severe Pyrimethamine Poisoning

Young Adults Aged 18 to 30 Years with Hodgkin Lymphoma Can Tolerate a Modified Version of the Combined Modality German Paediatric HD95 Protocol with Minimal Neurotoxicity and Excellent Outcome. Results of the UK NCRN 18–30 Study (CRUK/08/012)

Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively

the Utility of CD200 Expression In the Differentiation of Mantle Cell Lymphoma and B-Cell Chronic Lymphocytic Leukaemia: A Single Centre Experience.

The JAK2 V617F Mutation but NOT Platelet Parameters Predict Thrombotic RISK IN Patients with Philadelphia-Negative MYELOPROLIFERATIVE Disorders (MPDs).

Rituximab Does Not Increase the Complication Rate, Particularly Perforation, When Added to Chemotherapy for Patients with Primary B-Cell Lymphomas of the Gastrointestinal Tract.

Email alerts

ASH Publications

American Society of Hematology

Does Electrocardiogram Offer an Alternative to Radiological Imaging in the Confirmation of Tip Positioning for the Insertion of Peripherally Inserted Central Catheters; A Comparison of 120 Patients

Clinico-Pathologic Characteristics of Patients Experiencing Severe Pyrimethamine Poisoning

Young Adults Aged 18 to 30 Years with Hodgkin Lymphoma Can Tolerate a Modified Version of the Combined Modality German Paediatric HD95 Protocol with Minimal Neurotoxicity and Excellent Outcome. Results of the UK NCRN 18–30 Study (CRUK/08/012)

Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively

the Utility of CD200 Expression In the Differentiation of Mantle Cell Lymphoma and B-Cell Chronic Lymphocytic Leukaemia: A Single Centre Experience.

The JAK2 V617F Mutation but NOT Platelet Parameters Predict Thrombotic RISK IN Patients with Philadelphia-Negative MYELOPROLIFERATIVE Disorders (MPDs).

Rituximab Does Not Increase the Complication Rate, Particularly Perforation, When Added to Chemotherapy for Patients with Primary B-Cell Lymphomas of the Gastrointestinal Tract.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only